Papillary Adenocarcinoma of the Prostatic Urethra

Witters, S.; Moerman, Philippe; L, Vanden Bussche; Rl, Vereecken

doi:10.1159/000472600

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Those cases reported as endometrioid adenocarcinoma were identified. Clinical history and follow-up information, a mini-0 1994 Wiley-Liss, Inc. mum of 3 years up to 13 years from the establishment of diagnosis to the time of this study, were obtained by scrutiny of hospital records and surgical pathology reports. Additional follow-up information was acquired from referring physicians and telephone interviews of the patients or their family members.…”

Section: Methodsmentioning

confidence: 99%

Endometrioid adenocarcinoma of the prostate: A clinicopathologic and immunohistochemical study

Lee

1994

Journal of Surgical Oncology

View full text Add to dashboard Cite

On retrospective review of the tumor registry files between 1979 and 1992 at the North Iowa Medical Center, six cases of endometrioid adenocarcinoma of the prostate were identified among 1582 cases of prostatic carcinoma. Along with long-term clinicopathologic follow-up, immunohistochemical studies of the prostatic tumor tissues were performed. All six cases of endometrioid carcinoma, together with control cases of benign prostatic hypertrophy (BPH) and ordinary adenocarcinoma of the prostate had unequivocal diffuse positive staining for PSA and similar reactivity to ER-D5 and PS2. Thus, endometrioid carcinoma is most likely derived from the prostate or prostatic urethral duct rather than the utricle. However, due to its unusual initial clinical manifestations, biological behavior, and distinctive histomorphology, the term "endometrioid adenocarcinoma of the prostate" is worth preserving.

show abstract

Section: Methodsmentioning

confidence: 99%